7 September 2016

New Chief Executive Officer

The 1st of September 2016, Jan A. Alfheim entered the position as Chief Executive Officer (CEO) of Oncoinvent AS. Jan A. Alfheim comes from the position Chief Operation Officer (COO) in Nordic Nanovector ASA, where he until 2014 was responsible for the company’s leadership as CEO.

Tina B. Bønsdorff enters the position as Chief Scientific Officer (CSO) of Oncoinvent and Ole Peter Nordby has been appointed acting Chief Financial Officer (CFO).